Literature DB >> 31234753

Phenotypic transition of tumor cells between epithelial- and mesenchymal-like state during adaptation to acidosis.

Yongjun Zhang1, Lili Xu1, Ping Wang1, Huanzhang Jian1, Xianghua Shi2, Min Jia1, Lijun Mo1, Zhiming Hu1, Hongwei Li1, Jinlong Li1.   

Abstract

Acidic microenvironment is an important feature of solid tumors that contributes to malignant transformation. Low extracellular pH could promote epithelial-mesenchymal transition (EMT) thereby endowing tumor cells with higher invasive capability. However, the relation between EMT and tumor cell proliferation under long-term acidic condition is still not fully understood. Here, we show that tumor cells have undergone a phenotypic transition from EMT to mesenchymal-epithelial transition (MET) during adaptation to acidosis, and is closely related with cell proliferative state. Under early stage of acidic stress, tumor cells entered a non-cycling quiescent state with mesenchymal phenotype and expressed high level of stemness genes. Whereas, after long-term acid culture (2 months), acid-adapted cells resumed proliferating but lost mesenchymal phenotype. Further, our results show that the acid-adapted cells have distinct proliferative mechanism from non-acid cells, as the G1-S transcriptional factor E2F1 protein was not recovered in the adapted cells. Meanwhile, mini-chromosome maintenance 7 (MCM7) is shown to regulate the EMT to MET phenotypic transition, and is required for proliferation of the adapted cells under acidic condition. MCM7 Knockdown promoted mesenchymal phenotype and inhibited proliferation of the acid-adapted cells. While, MCM7 overexpression inhibited acid-induced EMT and supported tumor cell proliferation under acidic condition. Thus, our study provides evidence that tumor cells display phenotypic plasticity that allows them to survive acid stress.

Entities:  

Keywords:  Acidic microenvironment; MCM7; epithelial-mesenchymal transition; mesenchymal-epithelial transition

Year:  2019        PMID: 31234753      PMCID: PMC6681788          DOI: 10.1080/15384101.2019.1635868

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  39 in total

Review 1.  Paradoxes of eukaryotic DNA replication: MCM proteins and the random completion problem.

Authors:  Olivier Hyrien; Kathrin Marheineke; Arach Goldar
Journal:  Bioessays       Date:  2003-02       Impact factor: 4.345

2.  The cyclin D1-dependent kinase associates with the pre-replication complex and modulates RB.MCM7 binding.

Authors:  Andrew B Gladden; J Alan Diehl
Journal:  J Biol Chem       Date:  2003-01-07       Impact factor: 5.157

3.  Expression of Mcm7 and Cdc6 in oral squamous cell carcinoma and precancerous lesions.

Authors:  Chong-Jin Feng; Hui-Jun Li; Jian-Na Li; Yong-Jun Lu; Gui-Qing Liao
Journal:  Anticancer Res       Date:  2008 Nov-Dec       Impact factor: 2.480

4.  Excess MCM proteins protect human cells from replicative stress by licensing backup origins of replication.

Authors:  Arkaitz Ibarra; Etienne Schwob; Juan Méndez
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-25       Impact factor: 11.205

5.  Acidic environment modifies heat- or radiation-induced apoptosis in human maxillary cancer cells.

Authors:  T Ohtsubo; H Igawa; T Saito; H Matsumoto; H J Park; C W Song; E Kano; H Saito
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-04-01       Impact factor: 7.038

6.  Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in vitro.

Authors:  Brent P Mahoney; Natarajan Raghunand; Brenda Baggett; Robert J Gillies
Journal:  Biochem Pharmacol       Date:  2003-10-01       Impact factor: 5.858

7.  Dormant origins licensed by excess Mcm2-7 are required for human cells to survive replicative stress.

Authors:  Xin Quan Ge; Dean A Jackson; J Julian Blow
Journal:  Genes Dev       Date:  2007-12-15       Impact factor: 11.361

8.  The epithelial-mesenchymal transition generates cells with properties of stem cells.

Authors:  Sendurai A Mani; Wenjun Guo; Mai-Jing Liao; Elinor Ng Eaton; Ayyakkannu Ayyanan; Alicia Y Zhou; Mary Brooks; Ferenc Reinhard; Cheng Cheng Zhang; Michail Shipitsin; Lauren L Campbell; Kornelia Polyak; Cathrin Brisken; Jing Yang; Robert A Weinberg
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

9.  Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features.

Authors:  Mahitosh Mandal; Jeffery N Myers; Scott M Lippman; Faye M Johnson; Michelle D Williams; Suresh Rayala; Kazufumi Ohshiro; David I Rosenthal; Randal S Weber; Gary E Gallick; Adel K El-Naggar
Journal:  Cancer       Date:  2008-05-01       Impact factor: 6.860

10.  Generation of breast cancer stem cells through epithelial-mesenchymal transition.

Authors:  Anne-Pierre Morel; Marjory Lièvre; Clémence Thomas; George Hinkal; Stéphane Ansieau; Alain Puisieux
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

View more
  3 in total

1.  Circadian clock protein CRY1 prevents paclitaxel‑induced senescence of bladder cancer cells by promoting p53 degradation.

Authors:  Min Jia; Bijia Su; Lijun Mo; Wen Qiu; Jiaxu Ying; Peng Lin; Bingxuan Yang; Danying Li; Dongxia Wang; Lili Xu; Hongwei Li; Zhongxin Zhou; Xing Li; Jinlong Li
Journal:  Oncol Rep       Date:  2020-12-30       Impact factor: 3.906

2.  Gremlin-1 Promotes Colorectal Cancer Cell Metastasis by Activating ATF6 and Inhibiting ATF4 Pathways.

Authors:  Ruohan Li; Huaixiang Zhou; Mingzhe Li; Qiuyan Mai; Zhang Fu; Youheng Jiang; Changxue Li; Yunfei Gao; Yunping Fan; Kaiming Wu; Clive Da Costa; Xia Sheng; Yulong He; Ningning Li
Journal:  Cells       Date:  2022-07-07       Impact factor: 7.666

3.  MCM4 Is a Novel Biomarker Associated With Genomic Instability, BRCAness Phenotype, and Therapeutic Potentials in Soft-Tissue Sarcoma.

Authors:  Qi Liu; Qiyuan Bao; Yiqi Xu; Yucheng Fu; Zhijian Jin; Jun Wang; Weibin Zhang; Yuhui Shen
Journal:  Front Cell Dev Biol       Date:  2021-06-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.